Dupont Capital Management’s bluebird bio BLUE Stock Holding History

Dupont Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-443	Closed	-$310K	–	1305
2020 Q3	$310K	Sell	443 -94	-18%	-$73.3K	0.01%	959
2020 Q2	$424K	Buy	+537	New	+$405K	0.01%	847
2018 Q4	–	Sell	-192	Closed	-$363K	–	1166
2018 Q3	$363K	Buy	+192	New	+$397K	0.01%	788
2018 Q2	–	Sell	-588	Closed	-$1.3M	–	980
2018 Q1	$1.3M	Sell	588 -211	-26%	-$537K	0.03%	444
2017 Q4	$1.84M	Buy	799 +175	+28%	+$355K	0.04%	380
2017 Q3	$1.11M	Buy	624 +351	+129%	+$490K	0.03%	495
2017 Q2	$371K	Hold	273	–	–	0.01%	737
2017 Q1	$321K	Sell	273 -289	-51%	-$295K	0.01%	779
2016 Q4	$449K	Buy	+562	New	+$446K	0.01%	719
2015 Q3	–	Sell	-408	Closed	-$891K	–	596
2015 Q2	$891K	Sell	408 -223	-35%	-$454K	0.02%	449
2015 Q1	$988K	Buy	+631	New	+$833K	0.02%	449

Other funds holding BLUE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dupont Capital Management's BLUE Position: Q4 2020 in Review

Dupont Capital Management sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 443 shares — an estimated $310K sold.

Dupont Capital Management first reported a position in BLUE in Q1 2015 and held it in 11 quarters. The position peaked at $1.84M in Q4 2017. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

Dupont Capital Management reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
Dupont Capital Management sold 443 bluebird bio shares in Q4 2020, an estimated $310K.
Dupont Capital Management first reported a position in bluebird bio in Q1 2015 and held it in 11 quarters.
Dupont Capital Management's bluebird bio position peaked at $1.84M in Q4 2017.
262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Dupont Capital Management's 13F filing for Q4 2020, filed 28 Jan 2021.